ADPT

Adaptive Biotechnologies Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↑ 7/10
  • Value↓ 0/10
Adaptive Biotechnologies sales and earnings growth
ADPT Growth
Good
  • Revenue Y/Y↑ 54.77%
  • EPS Y/Y↑ 63.89%
  • FCF Y/Y↑ 50.50%
Adaptive Biotechnologies gross and profit margin trends
ADPT Profitability
Neutral
  • Gross margin ↑ 74.20%
  • EPS margin↓ -21.50%
  • ROIC 5Y↓ -25.99%
Adaptive Biotechnologies net debt vs free cash flow
ADPT Risk
Great
  • Debt / Equity↓ 0.9
  • Debt / FCF↓ 2.8
  • Interest coverage↓ -4.0

Adaptive Biotechnologies stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗